Search

everythinglearnresearchcommunity

for

Search:↓

Rumex japonicus extract may promote hair growth more effectively than Minoxidil.

5% minoxidil foam effectively regrows hair in women, with postmenopausal women seeing the most improvement.

Lespedeza bicolor extract promotes hair growth and increases hair follicle cell growth, potentially making it a better treatment than minoxidil.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.

JAK inhibitors are safe and effective for treating moderate-to-severe alopecia areata.

Edelweiss extract can increase hair density and promote hair growth.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Testosterone replacement therapy significantly improved sexual interest and function in HIV+ men.

Spironolactone may help reduce hair loss in androgenic alopecia.

Timosaponin BII, a plant extract, was found to promote hair growth in mice, similarly to minoxidil.

The botanical treatment for hair loss shows promise, especially for children.

Baricitinib helps improve hair growth in severe alopecia, with better results in less severe cases and higher doses working faster.

Self-monitoring blood pressure in pregnant women didn't improve outcomes, diabetes drugs may increase gallbladder disease risk, a new drug helps severe hair loss, a plant-based COVID-19 vaccine is 69.5% effective, and new anticoagulants are safer for diabetics with heart rhythm issues than warfarin.

Spironolactone may help reduce hair loss in androgenic alopecia.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A new protein linked to Alzheimer's was discovered, and a hair loss treatment showed effectiveness but had some sexual side effects.

Baricitinib effectively treats severe alopecia for up to 104 weeks.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Giving docetaxel weekly at 40 mg/m² is manageable and has low toxicity for cancer patients.

Rivaroxaban can cause liver injury, allergic reactions, blood vessel inflammation, and hair loss, but these side effects are rare.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

There are several promising treatments for hair loss, including dutasteride, latanoprost, ketoconazole shampoo, anti-androgens, laser/light treatment, and platelet-rich plasma, but more research is needed.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Bimatoprost is a safe and effective treatment for making eyelashes longer, thicker, and darker.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.